<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two genetic instability pathways viz. <z:mp ids='MP_0008866'>chromosomal instability</z:mp>, driven primarily by APC mutation induced deregulated Wnt signaling, and microsatellite instability (MSI) caused by mismatch repair (MMR) inactivation, together account for &gt;90% of <z:hpo ids='HP_0003584'>late-onset</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Our understanding of early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is however comparatively limited </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, most seminal studies have been performed in the western population and analyses of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> pathway(s) causing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in developing nations have been rare </plain></SENT>
<SENT sid="3" pm="."><plain>We performed a comparative analysis of early and <z:hpo ids='HP_0003584'>late-onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from India with respect to common genetic aberrations including Wnt, KRAS, and p53 (constituting the classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression sequence) in addition to MSI </plain></SENT>
<SENT sid="4" pm="."><plain>Our results revealed the absence of Wnt and MSI in a significant proportion of early-<z:hpo ids='HP_0003674'>onset</z:hpo> as against <z:hpo ids='HP_0003584'>late-onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in India </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, KRAS mutation frequency was significantly lower in early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> indicating that a significant proportion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in India may follow <z:mp ids='MP_0002006'>tumorigenesis</z:mp> pathways distinct from the classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression sequence </plain></SENT>
<SENT sid="6" pm="."><plain>Our study has therefore revealed the possible existence of non-canonical <z:mp ids='MP_0002006'>tumorigenesis</z:mp> pathways in early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in India. Â© 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>